
tavist
Pharmaranks rates Tavist 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Tavist (Clemastine Fumarate) is a medication used to treat Angioedema, Perennial Allergic Rhinitis, Urticaria.
Clemastine Fumarate · by Novartis
Available as a generic: Clemastine Fumarate
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Clemastine Fumarate
- Form
- Syrup, Tablet
- Strength
- Clemastine Fumarate 2.68MG **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons**
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- angioedema, perennial allergic rhinitis, urticaria
- Manufacturer
- Novartis
- What the pharmacy pays
- ~$5.46 per ml — not your price
- FDA application
- NDA017661
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Syrup and Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Tavist treat?
- Tavist (Clemastine Fumarate) may be used to treat angioedema, perennial allergic rhinitis, urticaria, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Tavist rated?
- pharmaranks gives Tavist a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- How much does Tavist cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $5.46 per ml, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins. Pharmacies pay less for a same-class option, Cromolyn Sodium — about $0.60 on the same basis.
- Is there a coupon or discount for Tavist?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Tavist. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Tavist?
- Tavist is marketed by Novartis. You can see Novartis's full profile, rating, and other products on pharmaranks.
- Is Tavist a brand-name or generic drug?
- Tavist is a brand-name product with the active ingredient Clemastine Fumarate. Lower-cost generic equivalents containing Clemastine Fumarate are available — ask your pharmacist.
- Is Tavist available over the counter?
- No. Tavist is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Tavist come in?
- Tavist is currently marketed as syrup and tablet, per the FDA's National Drug Code Directory.
- Is Tavist FDA-registered?
- Tavist is on record with the U.S. FDA under application number NDA017661. You can verify this on its official FDA label.
- Has Tavist been recalled by the FDA?
- Tavist has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Tavist safe?
- There's no single safe-or-not verdict. pharmaranks gives Tavist a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
atrovent hfa
Ipratropium Bromide
cromolyn sodium
Cromolyn Sodium
flonase allergy relief
Fluticasone Propionate
flunisolide
Flunisolide
montelukast sodium
Montelukast Sodium
arnuity ellipta
Fluticasone Furoate
Compare Tavist head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
tavist
70/100